524 related articles for article (PubMed ID: 19124423)
21. Atrial structural remodeling as an antiarrhythmic target.
Burstein B; Nattel S
J Cardiovasc Pharmacol; 2008 Jul; 52(1):4-10. PubMed ID: 18594481
[TBL] [Abstract][Full Text] [Related]
22. [Atrial fibrillation and renin-angiotensin system].
Yamashita T
Nihon Rinsho; 2007 Mar; 65(3):569-74. PubMed ID: 17354577
[TBL] [Abstract][Full Text] [Related]
23. [Non-channel drugs to prevent atrial fibrillation].
Fazekas T; Liszkai G
Orv Hetil; 2005 Nov; 146(45):2287-94. PubMed ID: 16304807
[TBL] [Abstract][Full Text] [Related]
24. [Atrial fibrillation: potential therapeutic interventions in the renin-angiotensin-aldosterone system].
Dabrowski R; Szwed H
Kardiol Pol; 2007 Apr; 65(4):440-5. PubMed ID: 17530565
[No Abstract] [Full Text] [Related]
25. Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers in atrial fibrillation.
Levine MJ; Schweitzer P
Vnitr Lek; 2010 Nov; 56(11):1138-41. PubMed ID: 21247007
[TBL] [Abstract][Full Text] [Related]
26. Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling.
Healey JS; Morillo CA; Connolly SJ
Curr Opin Cardiol; 2005 Jan; 20(1):31-7. PubMed ID: 15596957
[TBL] [Abstract][Full Text] [Related]
27. Renin-angiotensin system component expression in the HL-1 atrial cell line and in a pig model of atrial fibrillation.
Tsai CT; Lai LP; Hwang JJ; Chen WP; Chiang FT; Hsu KL; Tseng CD; Tseng YZ; Lin JL
J Hypertens; 2008 Mar; 26(3):570-82. PubMed ID: 18300870
[TBL] [Abstract][Full Text] [Related]
28. New antiarrhythmic agents for atrial fibrillation and atrial flutter.
Pecini R; Elming H; Pedersen OD; Torp-Pedersen C
Expert Opin Emerg Drugs; 2005 May; 10(2):311-22. PubMed ID: 15934869
[TBL] [Abstract][Full Text] [Related]
29. Atrial fibrillation and heart failure: natural history and pharmacological treatment.
Savelieva I; John Camm A
Europace; 2004 Sep; 5 Suppl 1():S5-19. PubMed ID: 15450275
[TBL] [Abstract][Full Text] [Related]
30. [Morphological remodeling in atrial fibrillation].
Goette A; Lendeckel U
Herz; 2006 Apr; 31(2):101-7; quiz 142-3. PubMed ID: 16738831
[TBL] [Abstract][Full Text] [Related]
31. Upstream therapy for atrial fibrillation.
Kumagai K
Circ J; 2007; 71 Suppl A():A75-81. PubMed ID: 17587744
[TBL] [Abstract][Full Text] [Related]
32. [Innovative therapeutic approach to atrial fibrillation: AT1-receptor blocker].
Goette A
Dtsch Med Wochenschr; 2006 Aug; 131(34-35 Suppl 4):S103-7. PubMed ID: 16921445
[No Abstract] [Full Text] [Related]
33. Prevention of remodeling in congestive heart failure due to myocardial infarction by blockade of the renin-angiotensin system.
Guo X; Saini HK; Wang J; Gupta SK; Goyal RK; Dhalla NS
Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):717-32. PubMed ID: 16076281
[TBL] [Abstract][Full Text] [Related]
34. Electrical remodeling in atrial fibrillation.
Dobrev D
Herz; 2006 Apr; 31(2):108-12; quiz 142-3. PubMed ID: 16738832
[TBL] [Abstract][Full Text] [Related]
35. [Drugs for heart rate control and non-antiarrhythmic drugs in atrial fibrillation].
Chávez LL
Arch Cardiol Mex; 2007; 77 Suppl 2():S2-54-S2-58. PubMed ID: 17972380
[TBL] [Abstract][Full Text] [Related]
36. Drug Insight: angiotensin-converting-enzyme inhibitors and atrial fibrillation--indications and contraindications.
Lévy S
Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):220-5. PubMed ID: 16568131
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis.
Huang G; Xu JB; Liu JX; He Y; Nie XL; Li Q; Hu YM; Zhao SQ; Wang M; Zhang WY; Liu XR; Wu T; Arkin A; Zhang TJ
Eur J Clin Invest; 2011 Jul; 41(7):719-33. PubMed ID: 21250983
[TBL] [Abstract][Full Text] [Related]
38. Atrial fibrillation and atrial fibrosis.
Tan AY; Zimetbaum P
J Cardiovasc Pharmacol; 2011 Jun; 57(6):625-9. PubMed ID: 21633248
[TBL] [Abstract][Full Text] [Related]
39. Atrial fibrillation: mechanistic insights and treatment options.
Mathew ST; Patel J; Joseph S
Eur J Intern Med; 2009 Nov; 20(7):672-81. PubMed ID: 19818285
[TBL] [Abstract][Full Text] [Related]
40. Blockade of angiotensin II improves hyperthyroid induced abnormal atrial electrophysiological properties.
Xiao P; Gao C; Fan J; Du H; Long Y; Yin Y
Regul Pept; 2011 Aug; 169(1-3):31-8. PubMed ID: 21545815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
